HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 2 filers reported holding HARPOON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | – | 843 | +40.5% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 600 | -47.8% | 0.00% | – |
| Q1 2022 | $6,000 | -82.4% | 1,149 | -74.1% | 0.00% | – |
| Q4 2021 | $34,000 | +183.3% | 4,433 | +176.5% | 0.00% | – |
| Q3 2021 | $12,000 | -33.3% | 1,603 | +24.4% | 0.00% | – |
| Q2 2021 | $18,000 | -33.3% | 1,289 | +2.9% | 0.00% | – |
| Q1 2021 | $27,000 | -94.4% | 1,253 | -95.7% | 0.00% | – |
| Q4 2020 | $480,000 | +0.8% | 28,920 | +3.3% | 0.00% | – |
| Q3 2020 | $476,000 | – | 27,995 | +164576.5% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 17 | -96.9% | 0.00% | – |
| Q4 2019 | $8,000 | +300.0% | 555 | +260.4% | 0.00% | – |
| Q3 2019 | $2,000 | – | 154 | +1000.0% | 0.00% | – |
| Q2 2019 | $0 | – | 14 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |